CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 28 enrolled
Drug / intervention
Test strip +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02275364
NCT02275364Phase 4Completed
CompareCT.gov

A Magnetic Resonance Imaging Study of Nasal Strips in Subjects With Nasal Congestion

GlaxoSmithKline·interventional·Posted Oct 27, 2014·Updated Aug 2, 2017

In Brief

A Phase 4 clinical trial evaluating Test strip, Placebo strip, and 1 other intervention for Nasal Congestion. Completed, enrolled 28 participants across 1 site.

Detailed Summary

The aim of the study is to evaluate the effect of the nasal strip (relative to the placebo strip) on the nasal passages using anatomical MRI scans and to demonstrate the effect of the strip on breathing correlated cortical activity, using interoceptive fMRI task and analysis techniques derived from physiological data collected during scanning.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNasal Congestion
CountriesUnited Kingdom
Collaborators--

Timeline

Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedOct 27, 2014
Enrollment StartAug 5, 2013
Primary CompletionOct 30, 2013
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 11.7 years ago

Interventions

Test stripdevice

Class I device for the application to the nose to facilitate better air flow through the nose

Placebo stripdevice

Placebo strip

Nasal sprayother

Nasal decongestant to be used on a single occasion (one spray per nostril), 20 minutes prior to commencing the third MRI scanning sessions.